PTC Therapeutics Wins First FDA Approval for a Gene Therapy Dosed Directly Into the Brain
An ultra-rare enzyme deficiency that keeps infants from achieving proper muscle function among other developmental delays now has its first FDA-approved treatment. The new product, a gene therapy developed by...